Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?

被引:1
|
作者
Park, Soo Jin [1 ]
Mun, Jaehee [1 ]
Yim, Ga Won [2 ]
Lee, Maria [1 ]
Chung, Hyun Hoon [1 ]
Kim, Jae Weon [1 ]
Park, Noh Hyun [1 ]
Song, Yong Sang [1 ]
Kim, Hee Seung [1 ]
机构
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Dongguk Univ, Dept Obstet & Gynecol, Coll Med, Goyang, South Korea
关键词
Aged; ovarian neoplasm; postoperative complications; prognosis; surgical procedure; CYTOREDUCTIVE SURGERY; CHEMOTHERAPY; MORBIDITY; COMORBIDITY; TOXICITY; OUTCOMES; RISK;
D O I
10.1080/01443615.2022.2112021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We collected data of elderly patients aged 65 years and older who underwent debulking surgery for advanced ovarian cancer in order to explore the impact of old age on surgical outcomes and complications. A total of 120 patients were classified as follows: group 1, 65-69 years (n = 58); group 2, 70-74 years (n = 38); group 3, 75-79 years (n = 17); group 4, >= 80 years (n = 7). There were no differences in most of the characteristics, surgical extent and outcomes, and postoperative complications between the four groups, whereas polypharmacy was more common (6 vs. 5-16; p=.02) and operation time was shorter (median, 194 vs. 285-330 min; p=.02) in group 4. Factors related to frailty rather than age, polypharmacy, preoperative albumin level, estimated blood loss and transfusion increased the risk of postoperative complications. Thus, the impact of old age on surgical extent, outcomes and postoperative complications may be minimal in elderly patients with advanced ovarian cancer. Impact Statement What is already known on this subject? Optimal debulking surgery is a significant factor in improving the prognosis of ovarian cancer but it is not easy to perform such radical surgery on elderly patients in fear of increasing surgical morbidity and mortality. Some studies suggest that underlying comorbidities may be a stronger contributing factor to increasing such risk rather than old age although there is not enough evidence yet. What do the results of this study add? Through this study, we could see that increased age is not the determining cause of increased morbidity and mortality in elderly patients who undergo optimal debulking surgery in ovarian cancer. There are other aspects describing a patient's health status that can predict prognosis better rather than age. What are the implications of these findings for clinical practice and/or further research? Old age need not be a contraindication when performing optimal debulking surgery in elderly patients with advanced ovarian cancer.
引用
下载
收藏
页码:3254 / 3259
页数:6
相关论文
共 50 条
  • [42] Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America
    Paulino, Eduardo
    Rodrigues, Angelica Nogueira
    Strasser-Weippl, Kathrin
    St Louis, Jessica
    Bukowski, Alexandra
    Goss, Paul E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (08) : 1645 - 1649
  • [43] Early debulking surgery following chemotherapy in advanced ovarian cancer.
    de Gramont, A
    Pigne, A
    Louvet, C
    Sezeur, A
    Marpeau, L
    Vaillant, JC
    Cady, J
    Varette, C
    Demuynck, B
    Couturier, JY
    Lagadec, B
    Milliez, J
    Barrat, J
    Krulik, M
    ANNALES DE CHIRURGIE, 1997, 51 (10): : 1069 - 1076
  • [44] Meigs to modern times: The evolution of debulking surgery in advanced ovarian cancer
    Schorge, John O.
    Bregar, Amy J.
    Durfee, John
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (03) : 447 - 454
  • [45] Assessment of peritoneal cytology in advanced-stage ovarian cancer patients at interval debulking surgery
    Kato, K.
    Omatsu, K.
    Nomura, H.
    Matoda, M.
    Matsuura, M.
    Katsuda, T.
    Okamoto, S.
    Kondo, E.
    Kanao, H.
    Utsugi, K.
    Sugiyama, Y.
    Takeshima, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 741 - 741
  • [46] Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer
    Chang, Suk-Joon
    Bristow, Robert E.
    Ryu, Hee-Sug
    GYNECOLOGIC ONCOLOGY, 2012, 126 (03) : 381 - 386
  • [47] The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with advanced ovarian cancer
    Goncalves, M. D.
    Vitarello, J.
    Zhou, Q.
    Iasonos, A.
    Halpenny, D.
    Mueller, J. J.
    Zivanovic, O.
    Cadoo, K. A.
    Konner, J.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 103 - 103
  • [48] Debulking Surgery for Locally Advanced Ovarian Sarcomas
    Balescu, Irina
    Vilcu, Mihaela
    Bacalbasa, Nicolae
    Brasoveanu, Vladislav
    Brezean, Iulian
    Orban, Carmen
    PROCEEDINGS OF THE 4TH CONGRESS OF THE ROMANIAN SOCIETY FOR MINIMAL INVASIVE SURGERY IN GINECOLOGY / ANNUAL DAYS OF THE NATIONAL INSTITUTE FOR MOTHER AND CHILD HEALTH ALESSANDRESCU-RUSESCU, 2019, : 89 - 92
  • [49] AGGRESSIVE CHEMOSURGICAL DEBULKING IN PATIENTS WITH ADVANCED OVARIAN-CANCER
    NG, LW
    RUBIN, SC
    HOSKINS, WJ
    JONES, WB
    HAKES, TB
    MARKMAN, M
    REICHMAN, B
    ALMADRONES, L
    LEWIS, JL
    GYNECOLOGIC ONCOLOGY, 1990, 38 (03) : 358 - 363
  • [50] Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian Cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery
    Ruiz Castro, Beatriz Guerreiro
    dos Reis, Ricardo
    Cintra, Georgia Fontes
    de Assuncao Sousa, Mileide Maria
    Vieira, Marcelo de Andrade
    Mattos da Cunha Andrade, Carlos Eduardo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1520 - 1528